title: Substance abuse treatment as HIV prevention: more questions than answers.
abstract: This report examines associations between the availability of human immunodeficiency virus (HIV)-related health services in substance abuse treatment programs and characteristics of the programs and the patients they serve. In a cross-sectional, descriptive design and via a validated survey, program administrators within the National Drug Abuse Treatment Clinical Trials Network provided information on program characteristics, patient characteristics (rates of risky sexual and drug behaviors and HIV infection), and the availability of 31 different HIV-related health services. Of 319 programs, 84% submitted surveys. Service availability rates ranged from: 10% (pneumococcal vaccination) to 86% (drug testing) for the 6 HIV-related services offered to all patients, 13% (Pap smear for women) to 54% (tuberculin skin testing) for the 6 services offered to new patients, 2% (sterile injection equipment) to 64% (male condoms) for the 4 risk-reduction services, 37% (Pap smear for women) to 61% (tuberculin skin testing) for the 11 biological assessments offered to HIV-positive patients, and 33% (medical treatments) to 52% (counseling) for the 4 other services offered to HIV-positive patients. The availability of these HIV-related services was associated with clinical settings, the types of addiction treatment services, the rates of risky drug and sexual behaviors, and HIV infection rates among patients. Availability of such services was below published guidelines. While the results provide another basis for the infection-related prevention benefits of substance abuse treatment, the variability in the availability of HIV-related health care deserves further study and has health policy implications in determining how to utilize substance abuse treatment in reducing drug-related HIV transmission.
authors.affiliation: Addiction Research and Treatment Corp, 22 Chapel St, Brooklyn, NY 11201, USA. lbrown@artcny.org
authors.forename: Lawrence S
authors.initials: LS
authors.lastname: Brown
authors.forename: Steven
authors.initials: S
authors.lastname: Kritz
authors.forename: Edmund J
authors.initials: EJ
authors.lastname: Bini
authors.forename: Ben
authors.initials: B
authors.lastname: Louie
authors.forename: Jim
authors.initials: J
authors.lastname: Robinson
authors.forename: Donald
authors.initials: D
authors.lastname: Alderson
authors.forename: John
authors.initials: J
authors.lastname: Rotrosen
mesh_terms: D003430:Cross-Sectional Studies; D005260:Female; D015658:HIV Infections / Q000517:prevention & control*; D006266:Health Education; D006801:Humans; D008297:Male; D012309:Risk-Taking; D012725:Sexual Behavior; D019966:Substance-Related Disorders / Q000628:therapy*